Potassium humate sales will rise through 2036, driven by liquid formulations at 38% of the product form segment in 2026. The market was valued at USD 748.1 million in 2025 and is expected to be worth USD 1.01 billion by 2036, creating an incremental opportunity of USD 244.6 million.